Get Global Biopharmaceuticals Outlook by MP Advisors at a Special Price at MarketPublishers.com

17 Mar 2015 • by Natalie Aster

LONDON - TD The Market Publishers Ltd. is happy to announce a special discount offer on behalf of its market research partner, MP Advisors.

Get Global Biopharmaceuticals Outlook 2015 prepared by the publisher at a special price of USD 9,000 (25% off). This outlook includes 6 research reports, with each study costing USD 2,000 if it is purchased individually. Please note that India Rising Stars Outlook 2015 will be included into the Global Rising Stars Outlook 2015 in case all reports are acquired simultaneously.

The following publications are included in the Global Biopharmaceuticals Outlook:

Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success. In 2014, all biotechnology companies have given a positive return. As a result, biotech investors became more interested in their activities.  At present, pharma large caps focus mainly on activities related to mergers and acquisitions, while biotech majors prefer to remain stick to the core expertise, besides venturing into new or unexplored therapy. The research report offers a deep insight into the biotechnology marketplace. It makes a special focus on top market players by reviewing their products, covering their activities, and more …

Global Rising Stars Outlook 2015: Innovative Therapies for Treating Diseases are Being Sought after with Fresh Vigor as New Targets. Pharma companies continuously work on innovative therapies that can be used to treat various diseases. Though a large number of companies are active in the global marketplace, new player continue to enter the market. At present, there are some companies that have turned into rising stars of the pharma universe. For instance, Orgenesis (a US-headquartered company) focuses on the treatment of diabetes, while Cellworks (with its HQ in the USA) focuses on personalized medicine and cancer therapy. The report provides detailed coverage of rising stars of the global pharma market …

Global Pharma US & EU Outlook 2015: First –In- Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies. Several new therapies have been approved in the recent years. They were in the area of HCV, multiple sclerosis, breast cancer, diabetes and melanoma. Some of the, are expected to hit the multibillion dollar mark in terms of sales in the near term. Anti-PCSK9, anti-PD1 and CDK inhibitors have attracted attention of market majors. Many companies are currently in the race to het a slice of this lucrative pie. The research report offers an insightful analysis of the US and EU pharma markets. It reviews top market players …

Japan Pharma Outlook 2015: 2015 –Year to Watch Out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives. A new pricing system introduced in H1 2014 in Japan led to manifold changes in the country’s pharma market since it impacted most of players. As a result, the companies are forced to revalidate strategies they use both in the local marketplace and overseas. In the near term, the number of collaborations between Japanese and foreign companies is expected to grow. The research study offers in-depth coverage of the Japanese pharma market. It scrutinizes performance of 13 major local biopharma companies …

India Pharma Outlook 2015: Accelerating Growth to the Next Level: Moving up the Value Chain Beyond Generics. In 2014, pharma sales increased in India following a slump having taken place a year earlier. The growth is forecast to continue in 2015 due to favorable economic situation and growing spending on healthcare. Currently, the USA is a key destination for India’s generic exports. Indian companies also aim at deepening their footprint in markets of Venezuela, Brazil, Mexico and countries of Eastern Europe. The research reports provides a comprehensive guide to the Indian pharma market, covers its participants, examines their activities …

India Rising Stars Outlook 2015: Traditionally Innovation and Drug Discovery Had Taken a Back Seat in the Indian Pharma Industry with a Few Blips Here and There. In India, innovation and drug discovery companies cannot boast leading positions in the local pharma market. However, a number of new players have emerged recently that are expected to change the situation in the years to come. The research study offers a comprehensive discussion of rising stars of the India pharma marketplace. It discloses their technology platforms, therapy focuses, key milestones, main activities. Some of the companies reviewed comprise: Bugworks, Tergene, Connexios, …

Sri Lanka Pharma Market Outlook 2015: More Beyond Importers & Distributors. Pharma companies from Sri Lanka are expected to penetrate in the global marketplace, while the country did not export pharma products in the recent past. Local healthcare arena is expected to remain largely dependent on the government sector, though a role of the private sector is forecast to grow. This research report provides a deep insight into performance of the pharma market in Sri Lanka. The study offers a thorough overview of the market, uncovers historical data and contain forecast figures, … 

More information about the offer can be found at the offer page. 

CONTACTS

The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected] 
MarketPublishers.com